Enhanced stability of L-asparaginase by its bioconjugation to poly(styrene-co-maleic acid) and Ecoflex nanoparticles

IET Nanobiotechnology
Jaleh Varshosaz, Negin Anvari

Abstract

Acute lymphoblastic leukemia (ALL) is the white blood cell cancer in children. L-asparaginase (L-ASNase) is one of the first drugs used in ALL treatment. Anti-tumor activity of L-ASNase is not specific and indicates limited stability in different biological environments, in addition to its quick clearance from blood. The purpose of the present study was to achieve a new L-ASNase polymer bioconjugate to improve pharmacokinetic, increase half-life and stability of the enzyme. The conjugations were achieved by the cross-linking agent of 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide (EDC) which activates the carboxylic acid groups of polymeric nanoparticles to create amide bond. EDC conjugated the L-ASNase to two biodegradable polymers including; Ecoflex® and poly (styrene-co-maleic acid) (PSMA) nanoparticles. To achieve optimal L-ASNase nanoparticles the amounts of each polymer and the crosslinker were optimized and the nanoparticles were characterized according to their particle size, zeta potential and percent of conjugation of the enzyme. The results showed that conjugated enzyme had more stability against pH changes and proteolysis. It had lower Km value (indicating more affinity to the substrate) and greater half-life in pl...Continue Reading

References

Jul 28, 1978·Biochemical and Biophysical Research Communications·Y AshiharaY Inada
Jan 1, 1973·Advances in Enzymology and Related Areas of Molecular Biology·J C Wriston, T O Yellin
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M M GasperM J Alonso
Apr 5, 2000·Pharmaceutica acta Helvetiae·A L StecherJ Abrahão-Neto
Apr 17, 2002·International Journal of Pharmaceutics·Alexandre Learth SoaresJosé Abrahão-Neto
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Aug 17, 2005·Journal of Biotechnology·Yu-Qing ZhangKenji Kiguchi
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Oct 25, 2007·Clinical Pharmacology and Therapeutics·L ZhangO C Farokhzad
Sep 3, 2013·International Journal of Biological Macromolecules·Hajar AshrafiSaeid Daneshamouz

❮ Previous
Next ❯

Citations

Jul 31, 2018·Expert Opinion on Drug Metabolism & Toxicology·Shenglei YanJingqing Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.